Huhtaniemi I (2014) Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 16:192–202PubMedCentralPubMed

Huhtaniemi I, Forti G (2011) Male late-onset hypogonadism: pathogenesis, diagnosis and treatment. Nat Rev Urol 8(6):335–344PubMed

Ip FF, di Pierro I, Brown R, Cunningham I, Handelsman DJ, Liu PY (2010) Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets. Eur J Endocrinol 162(2):385–390PubMed

Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, Porst H, Salonia A, Traish AM, Maggi M (2014) A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol 65(1):99–112PubMed

Jain P, Rademaker AW, McVary KT (2000) Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol 164(2):371–375PubMed

Johnson JM, Nachtigall LB, Stern TA (2013) The effect of testosterone levels on mood in men: a review. Psychosomatics 54(6):509–514PubMed

Karazindiyanoglu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11(3):146–149PubMed

Kelleher S, Conway AJ, Handelsman DJ (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89(8):3813–3817PubMed

Khera M, Crawford D, Morales A, Salonia A, Morgentaler A (2014) A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 65(1):115–123PubMed

Laurent M, Antonio L, Sinnesael M, Dubois V, Gielen E, Classens F, Vanderschueren D (2014) Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl 16:213–222

Lin JW, Lee JK, Wu CK, Caffrey JL, Chang MH, Hwang JJ, Dowling N, Lin YS (2011) Metabolic syndrome, testosterone, and cardiovascular mortality in men. J Sex Med 8(8):2350–2360PubMed

Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ (2003) The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 88(8):3605–3613PubMed

Lopez-Jimenez F, Sert Kuniyoshi FH, Gami A, Somers VK (2008) Obstructive sleep apnea: implications for cardiac and vascular disease. Chest 133(3):793–804PubMed

Lyngdorf P, Hemmingsen L (2004) Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. Int J Impot Res 16(2):105–111PubMed

Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL, Meikle AW, Center JR, Eisman JA, Seibel MJ (2008) Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 168(1):47–54PubMed

Meikle AW, Arver S, Dobs A, Sanders SW, Mazer NA (1996) Androderm: a permeation-enhanced, non-scrotal testosterone transdermal system for the treatment of male hypogonadism. In: Bhasin S (ed) Pharmacology, biology, and clinical applications of androgens. Wiley Liss, Inc, New York, pp 449–457

Michael H, Harkonen PL, Vaananen HK, Hentunen TA (2005) Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 20(12):2224–2232PubMed

Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO (2004) Endocrine aspects of sexual dysfunction in men. J Sex Med 1(1):69–81PubMed

Morales A, Schulman CC, Tostain J, Wu FC (2006) Testosterone Deficiency Syndrome (TDS) needs to be named appropriately–the importance of accurate terminology. Eur Urol 50(3):407–409PubMed

Morgentaler A (2007) Testosterone replacement therapy and prostate cancer. Urol Clin North Am 34(4):555–563PubMed

Morgentaler A (2009) Rapidly shifting concepts regarding androgens and prostate cancer. ScientificWorldJournal 9:685–690PubMed

Morgentaler A, Schulman C (2009) Testosterone and prostate safety. Front Horm Res 37:197–203PubMed

Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D Jr, Khera M (2011) Testosterone therapy in men with untreated prostate cancer. J Urol 185(4):1256–1260PubMed

Morley JE, Perry HM 3rd, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM Jr (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41(2):149–152PubMed

Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC (2004) Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 10(5):409–419PubMed